Introduction {#s0005}
============

The pancreas is a vertebrate-specific endodermal organ with essential functions in food digestion and glucose homeostasis. The mature organ is composed of an exocrine compartment with acinar and duct cells that produce and transport digestive enzymes into the gut, and an endocrine compartment from which metabolism-regulating peptide hormones are secreted into the blood stream. In higher vertebrates, endocrine cells are arranged in small clusters termed islets (islet of Langerhans in mammals) that contain up to five cells types each expressing a specific hormone: α-, β-, δ-, ε- and PP cells expressing *glucagon* (*gcg*), *insulin* (*ins*), *somatostatin* (*sst*), *ghrelin* and *pancreatic polypeptide* (*pp*), respectively. Formation of the pancreas can be formally divided into two phases termed primary and secondary transition. In amniotes, primary transition refers to the outgrowth of epithelial buds of dorsal and ventral foregut endoderm into the surrounding pancreatic mesenchyme demarcating the onset of pancreas morphogenesis. During this process, a population of postmitotic endocrine cells of unknown function, also termed 'first wave' cells, is established. Secondary transition defines the subsequent massive proliferation and expansion of the pancreatic buds and the accompanying differentiation of exocrine and 'second wave' endocrine cells from which the organ is finally formed ([@bib42]).

Genetic studies have been extremely successful in defining the importance of specific signaling pathways and transcription factors in regulating pancreas development. While the mouse has been the major model for such studies, more recently the zebrafish had gained attention as a model that is readily amenable to genetic and in vivo imaging approaches ([@bib10; @bib26; @bib28; @bib47]). Importantly, pancreas in mouse and fish has a conserved physiological function, a very similar cellular architecture, and conserved expression and function of most developmental genes ([@bib9; @bib22; @bib51]). Despite these similarities, studies in fish also revealed some evolutionary differences between mammalian and fish pancreas development.

Pancreas development in zebrafish is morphologically visible at 24 h post fertilization (24 hpf) by the formation of an endocrine cluster of 50--60 cells that are located dorsal to the gut endoderm ([@bib5; @bib26]). This early islet separates from the endoderm and by 48 hpf becomes encircled by a second endodermal protrusion. Based on their position and by analogy to the buds formed during primary transition in mouse, the early islet and the later forming protrusion in zebrafish have been termed dorsal and ventral bud, respectively ([@bib10]). However, the fates of these buds are different in mouse and fish. In mouse, the dorsal and ventral bud both contributes to first and second wave endocrine, as well as to exocrine cells ([@bib42]). By contrast, zebrafish dorsal bud consists exclusively of first wave endocrine cells (dorsal bud derived cells, DBCs), while the ventral bud gives rise to second wave endocrine (hereafter termed ventral bud derived cells, VBCs), exocrine and duct cells, and thus to all cells forming the mature pancreas ([@bib10; @bib18; @bib50]). Further, first wave cells in mouse mainly express *Gcg*, while in fish, at least 4 early endocrine cell types, expressing *Gcg* (α-cells), *Ins* (β-cells), *Sst* (δ-cells) and *Ghrelin* (ε-cells) can be distinguished ([@bib18; @bib42; @bib47]).

Correlating with these differences, the molecular control underlying formation of the two pancreatic buds appears slightly different in mouse and fish. Differences were found for example for the role of the homeobox transcription factors *Pdx1* and *Mnx1*/*Hb9*, that both show a conserved expression in pre-pancreatic endoderm and later in differentiating β-cells. In mouse knock-out studies the two phases of expression were shown to be required for early pancreas morphogenesis and for β-cell maturation ([@bib16; @bib31; @bib32; @bib41; @bib42]). By contrast, morpholino-based (MO) knockdown studies of these genes in fish revealed no major defects in early pancreas morphology but did provide evidence for a conserved function in specifying second wave endocrine cells (*pdx1*) and β-cell maturation (*hb9*) ([@bib27]). These data revealed differences mainly in the regulation of early pancreas morphogenesis and in first wave endocrine specification in fish and mouse. Formation of second wave endocrine cells appears to be more similar in fish and mouse, even though not that much is known about these processes in zebrafish.

In this study, we focus on the LIM-Homeodomain (LIM-HD) transcription factor *isl1* (Insulin gene enhancer protein 1) which in mouse has been shown to be required for early pancreas morphogenesis and endocrine differentiation ([@bib1; @bib8; @bib34; @bib35; @bib37]). While initially identified as a direct regulator of insulin expression in RIN 14B endocrine cells ([@bib23]), *isl1* in zebrafish shows evolutionary conserved expression in pancreatic mesenchyme during embryogenesis and in endocrine cells of the embryonic and adult pancreas, including first wave endocrine cells ([@bib36]). Mesenchymal *isl1* expression is limited to the initial stages of pancreas development. In mouse, this expression is restricted to the cells flanking the dorsal pancreatic endoderm ([@bib1]), while in fish expression is found in the vicinity of the late forming ventral bud. Knock-out analyses in the mouse revealed that the distinct expression domains in mesenchyme and endoderm are independently required to induce formation of the dorsal pancreatic bud and pancreatic mesenchyme and to initiate endocrine hormone expression, respectively. Due to the lethality of the *Isl1* mutant shortly after onset of pancreas morphogenesis, analyses of later pancreatic fates could only be done in organ culture. It was found that wild type but not *Isl1* mutant pancreatic mesenchyme is able to induce differentiation of exocrine tissue in co-cultured mutant dorsal endoderm, demonstrating a non-cell autonomous function of mesenchymal *Isl1* in inducing exocrine pancreas ([@bib1]).

More recently, a conditional knock-out approach has been used to address *Isl1* functions in second wave endocrine cells. Based on a *Pdx1*-Cre driven knock-out strategy, it was possible to efficiently remove endodermal *Isl1* expression shortly after onset of secondary transition ([@bib8; @bib34]). In these mutants, expression of the endocrine progenitor marker Pax6 was initiated in normal numbers but unlike in the control embryos, only a few of these Pax6 positive cells established expression of the hormones Gcg, Ins, Sst and PP. During later development, the mutants displayed a reduced number of Pax6 expressing endocrine cells and this reduction was accompanied by a decreased rate of β-cell proliferation and an increased rate of apoptosis within the pancreatic islet ([@bib8]). Furthermore, a transgenic increase of *Isl1* expression was shown to enhance glucose-induced insulin secretion ([@bib35]). The mouse data reveal requirements for *Isl1* during induction of exocrine tissue and for the expansion, maturation and physiological responses in endocrine cells. Moreover, molecular approaches provided first hints for the molecular targets and interaction partners of *Isl1. MafA* and *Arx*, two genes playing fundamental roles in the process of β- and α-cell differentiation, have been found as direct transcriptional targets of mouse *Isl1* ([@bib8; @bib34]). In vitro studies also identified *Isl1* as a direct regulator of *c-Myc* and *Cyclin D1*, providing a possible link between *Isl1* function and regulation of islet-cell proliferation ([@bib15]). Most recently, the Lim-domain-binding coregulator Ldb1 was shown to be a critical cofactor for Isl1-dependent expression of *MafA*, *Arx*, *ins* and *Glp1r*, which encodes an important regulator of Ins synthesis and release ([@bib19]).

Though pancreatic expression of *Isl1* is highly conserved, its functions have not been analyzed in any model system besides the mouse. In order to study pancreatic *isl1* functions in a non-mammalian system, we make use of a recently described *isl1* TILLING mutant in zebrafish. In these fish, an A to T transition creates a premature stop codon at amino acid 88 leading to a complete loss of the homeodomain ([@bib52]). Mutants are viable until late embryogenesis and therefore enable studies on *isl1* function during both early and later stages of pancreas development. In contrast to mouse, we find that *isl1* in zebrafish is not essential for pancreatic mesenchyme formation or for the formation of hormone-expressing first wave endocrine cells. We show that *isl1* has overlapping function with *isl2a* and *isl2b* in pancreatic mesenchyme in promoting expansion of the exocrine pancreas. We also show that *isl1* alone has cell type specific functions in endocrine cell maturation, and that these functions are different in first and second wave endocrine cells. The data reveal *isl1* functions that are unexpected when considering the mouse data, and show a major difference in the molecular regulation of first and second wave cells in zebrafish.

Materials and methods {#s0010}
=====================

Zebrafish maintenance and fish lines {#s0015}
------------------------------------

Zebrafish (*danio rerio*) were maintained according to standard protocols. Developing embryos were staged by hours post fertilization (hpf) when incubated at 28 °C ([@bib25]). Embryos older than 24 hpf were treated with 0.2 mM PTU to prevent pigmentation. *isl1*^*sa0029+/−*^ fish ([@bib52]) were obtained from the Sanger Institute (Cambridge/UK). Homozygous *isl1* mutant embryos were identified either based on the absence of a touch response (at 24 hpf) or by the lack of GFP labeled motoaxons in *tg\[hb9:GFP\]*^*ml2*^ transgenic background ([@bib3; @bib12]). *tgBAC\[NeuroD:EGFP\]*^*nl1*^ fish were obtained from Teresa Nicolson ([@bib40]). Fixed homozygous *cloche* mutants ([@bib45]) and control littermates were obtained from Arndt Siekmann.

Whole-mount in situ hybridization {#s0020}
---------------------------------

In situ hydridization was performed with digoxigenin labeled antisense RNA probes (DIG RNA Labeling Mix, Roche) and α-Digoxigenin-AP antibody (1:4000, Roche) using previously published protocols ([@bib17]). Antisense RNA probes were generated after linearizing the corresponding plasmids and using T7 or Sp6 RNA Polymerase. The following probes were used: *isl1* ([@bib14]), *isl2a* ([@bib14]), *isl2b* (gift from Hitoshi Okamoto) ([@bib24; @bib48]), *insulin*, *glucagon, somatostatin*, *ghrelin* (all kindly provided by Francesco Argenton) ([@bib2; @bib5]), *pax6b*, *meis3*, *fgf10*, *fgf24*, *arx* (gifts from Bernard Peers) ([@bib11; @bib36; @bib38; @bib43; @bib44]).

Immunofluorescence {#s0025}
------------------

Embryos were fixed for 90 min at room temperature in 4% PFA, 1% DMSO. After fixation, the embryos were washed 3×5 min in 1x PBS, 0.1% Tween 20, the yolk was removed and embryos were incubated in blocking buffer containing 1% DMSO, 1% sheep serum, 1% BSA and 1% Triton X-100 in 1x PBS for at least 60 min at room temperature. The embryos were then incubated overnight at +4 °C with primary and secondary antibodies, at 1:200 and 1:1000 dilutions, respectively. Primary antibodies: polyclonal guinea pig anti-insulin (Dako; A0564), polyclonal rabbit anti-human glucagon (Dako; A0565), polyclonal rabbit anti-somatostatin (Dako; A0566), anti-Islet-1 & 2 homeobox (mouse, 39.4D5; DSHB) and monoclonal mouse IgG anti-GFP (Roche, Cat. no. 11814460001). Secondary antibodies: Alexa Fluor 488 goat anti-mouse IgG (Invitrogen; A-11029), Alexa Fluor 555 goat anti-guinea pig IgG (Invitrogen; A-21435), Alexa Fluor 546 goat anti-rabbit IgG (Invitrogen, A-11035**)**, Alexa Fluor 633 goat anti-rabbit IgG (Invitrogen; A-21070), Alexa Fluor 633 goat anti-guinea pig IgG (Invitrogen; A-21105), and mouse Goat IgG, Cy3-conjugated (Chemicon; AP124C).

Morpholino and mRNA Injections {#s0030}
------------------------------

For knockdown of *isl2a and isl2b*, embryos were injected with a total of 4--8 pg morpholino (GenTools, Philomath, OR, USA).

MO^*isl2a*^: 5′-GAATATCCACCATACAGGAGGGTTA-3′ ([@bib20])

MO^*isl2b*^: 5′-TATTATATCCACCATACAGGTTGCC-3′

*H2B-mRFP1* encoding mRNA was produced from NotI linearized p13-pCS-H2B-mRFP1 (kindly provided by S.G. Megason) using Sp6 RNA Polymerase and mMessageMachine (Ambion). For injection, the *H2B-mRFP1* mRNA was diluted to 60 ng/µl. Eggs were collected shortly after fertilization, transferred to injection ramps and injected with 1--3 nl of mRNA solution before they reached the 2-cell stage. 6 h after injection, RFP^+^ eggs were sorted out and kept at 28 °C in the dark until the embryos were fixed for further analyses.

TUNEL staining {#s0035}
--------------

Embryos were fixed for 1 h at room temperature in 4% PFA, 1% DMSO. The yolk was removed and embryos were permeabilized by incubation in 1x PBS, 0.3% Triton X-100 for 20 min at room temperature. After Proteinase K digestion (10 µg/ml) and re-fixation in 4% PFA for 20 min at room temperature, the staining was performed using the In situ Cell Death Detection Kit, TMR red (Roche, Cat. no. 12156792910) according to manufactors instructions.

EdU staining {#s0040}
------------

For EdU based detection of proliferating cells, the Click-IT 647 Kit (Invitrogen C10085) was used. At 48 hpf, 5 nl EdU solution (50 μM EdU/2% DMSO) was injected into the yolk and common cardinal vein ([@bib29]) of PTU-treated embryos anaesthesyed with 0.6 mM tricaine. Injected fish were successively incubated in 50 µM EdU/0.4% DMSO and kept in the dark up to 96 hpf. Samples were fixed in 4% PFA/1% DMSO for 2 h at room temperature (RT), washed in 1x PBST and deyolked. EdU staining was performed as previously described ([@bib18]).

qPCR {#s0045}
----

Total RNA samples were prepared from pools of 15--20 embryos at the stages indicated and from pools of 25--30 manually dissected embryonic pancreata of 4 dpf *tg\[hb9:GFP\]^ml2^* embryos using Trizol Reagent (Ambion). cDNA was prepared using the First Strand cDNA Synthesis Kit \#K1641 (Thermo Scientific). HOT FirePol EvaGreen qPCR Mix Plus (Solis BioDyne, Cat.No. 08-24-00020) was used for qPCR reactions in a CFX Connect Real-Time System (Bio Rad). Reactions were performed on two biological samples with two technical replicates each. Primers were designed using the Software "QuantPrime" ([@bib4]) and are listed in the supplementary information ([Table. S7](#s0115){ref-type="fn"}).

Microscopy {#s0050}
----------

Confocal images were generated as previously described ([@bib3]) with a Zeiss LSM Exciter5 microscope equipped with the following lasers: 25 mW Argon laser (468, 488 and 514 nm), 1 mW 543 nm HeNe-laser, 5 mW 633 nm HeNe-laser and a 25 mW 405 nm diode-laser. Fluorescence detection was performed with the following filters: BP 505--530 (GFP and Alexa 488), LP 560 (Cy3, Alexa 555) and LP 650 (Alexa 633, Click-IT 647). A Leica DM 6000 microscope and Leica DFC300 FX camera was used for DIC images of whole mount in situ staining. Phenotypes of *isl1* mutant embryos were captured on a Leica MZ16A stereomicroscope using a Leica DFC320 camera. Adobe Photoshop CS3 was used for image arrangement and adjustment.

Statistics {#s0055}
----------

Statistical analysis was performed by GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA) using 1-way ANOVA and Tukey--Kramer Test ([Figs. 1](#f0005){ref-type="fig"}, [5](#f0025){ref-type="fig"}I, [7](#f0035){ref-type="fig"}G, [8](#f0040){ref-type="fig"} and [S3](#s0115){ref-type="fn"}) or unpaired *t*-test ([Figs. 4, 7](#f0035){ref-type="fig"}H & [S3](#s0115){ref-type="fn"}). For qPCR data, unpaired *t*-test ([Fig. 1](#f0005){ref-type="fig"}) and 1-way ANOVA with Bonferroni\'s Multiple Comparison Test ([Figs. 2 and 5](#f0010 f0025){ref-type="fig"}) was used. *P*-values for statistical significance are shown in each figure. All graphs show Mean+standard error (SEM).

Measuring of exocrine pancreas {#s0060}
------------------------------

The length of the exocrine pancreas was measured from head to tail of trypsin stained embryos. Images were taken using a 10x Ph1 Objective and a Leica DM6000 microscope. The longest possible distance from the head to the tail of the exocrine pancreas was measured using the Fiji plugin "Scale Bar tools for microscope" by Gilles Carpentier (Carpentier G. Contribution: Scale Bar Tools for Microscop ImageJ News, 4 June 2009).

Results {#s0065}
=======

*isl1* is required for proper formation of α-, β- and δ-cells {#s0070}
-------------------------------------------------------------

Previous analyses of the zebrafish TILLING mutation *isl1*^*sa0029*^ ([@bib52]) showed that homozygous mutant fish, unlike the *Isl1* mouse mutants, are viable until late embryogenesis (see also [Fig. S1](#s0115){ref-type="fn"}). Taking advantage of the long survival we asked if *isl1* has an evolutionary conserved requirement during pancreas formation. Immunostainings with antibodies against endocrine hormones at 28 hpf, 48 hpf and 76 hpf revealed a reduction of more than 50% in the number of Ins and Sst expressing cells in the mutants compared to phenotypic control littermates ([Fig. 1](#f0005){ref-type="fig"}A, F and M). An even more dramatic reduction was found for the number of Gcg^+^ cells, which were virtually absent in mutant embryos at 48 hpf and only very few Gcg^+^ cells could be detected at 72 hpf and 96 hpf ([Fig. 1](#f0005){ref-type="fig"}G, M, and [Table. S1](#s0115){ref-type="fn"}). The reduced number of endocrine hormone expressing cells in *isl1* mutants was confirmed by whole-mount in situ hybridization analyses for *ins* and *sst2* at 24 hpf, 48 hpf and 72 hpf ([Fig. S2](#s0115){ref-type="fn"}A--L) and for *gcga* at 52 hpf, 72 hpf and 96 hpf ([Fig. S2](#s0115){ref-type="fn"}M--R). Notably, control and *isl1* mutant embryos both showed 1--2 *ghre* mRNA positive cells per embryo suggesting that ε-cell formation is not affected in *isl1* mutants (data not shown). Quantitative RT-PCR (qPCR) analyses on mRNA from 28 hpf and 96 hpf embryos further confirmed reduced expression of *ins* (11%±2% at 28 hpf, 32%±3% at 96 hpf), *sst2* (19%±2% at 28 hpf, 41%±2% at 96 hpf) and *gcga* mRNA (52%±6% at 28 hpf, 62%±15% at 96 hpf). The robust decrease of *ins* and *sst2* at 28 hpf suggests that in mutants, hormone expressing cells are not only reduced in number but in addition express lower concentrations of *ins* and *sst2* mRNA. In summary, these data reveal a conserved requirement of *isl1* for α-, β- and δ-cell formation.

Conserved requirement for *isl1* in endocrine cell maturation {#s0075}
-------------------------------------------------------------

To investigate if the reduction of endocrine hormones reflects a loss of endocrine cells, we studied expression of *isl1* mRNA, which is stable in *isl1*^*sa0029*^ mutants. The clustering of *isl1* expressing cells into an islet and the size of these islets appeared indistinguishable between mutants and control embryos at 48 hpf and 76 hpf ([Fig. 2](#f0010){ref-type="fig"}A--F). Further, the numbers of *isl1*^*+*^ cells are similar in control embryos (48 hpf: 42.8±1,1 (*n*=8); 76 hpf: 56.8±2,4 (*n*=9)) and *isl1* mutants (48 hpf: 43.0±1,2 (*n*=6); 76 hpf: 54.5±1.67 (*n*=7)), suggesting that in *isl1* mutants endocrine cells are specified to adopt an endocrine fate, but fail to differentiate or mature into hormone producing cells. Consistent with this notion, we also find that the endocrine progenitor marker *pax6b* is expressed in similar numbers in control (38.6±1.1, *n*=10) and in *isl1* mutants (39.8±0.7, *n*=10) at 24 hpf ([Fig. 2](#f0010){ref-type="fig"}G, H, and [Table. S2](#s0115){ref-type="fn"}) and in a comparable domain at 76 hpf ([Fig. 2](#f0010){ref-type="fig"}I and J).

Next, we asked if the conserved requirement of *isl1* in endocrine differentiation is also associated with a conserved molecular function. Whole mount expression analyses of 24 hpf and 48 hpf embryos show that one of the few known pancreatic *isl1* targets in mouse, the transcription factor *arx*, is selectively lost in the pancreas of *isl1* mutant zebrafish embyros ([Fig. 2](#f0010){ref-type="fig"}K--P). For quantitative analyses of islet specific expression levels in 96 hpf embryos, we performed qPCR analyses on pools of 25--30 isolated pancreata. Using the relative expression levels of *ins* obtainted for 96 hpf whole embryonic RNA ([Fig. 1](#f0005){ref-type="fig"}N) for islet-specific normalization of these data, we found a 7-fold reduction of pancreatic *arx* expression in mutants. Using the same normalization approach we also determined expression level of additional transcription factors with an islet-restricted expression in the pancreas. In agreement with our whole mount expression studies, no differences were found for the expression of endocrine progenitor markers including *pax6b*, *isl1 neuroD and mnx1,* while expression of *ins*, *gcga* and *sst2* were strongly reduced ([Fig. 2](#f0010){ref-type="fig"}Q). These data suggest a conserved molecular function of *isl1* in endocrine cell maturation.

Overlapping expression of *isl1*, *isl2a* and *isl2b* in pancreas mesenchyme {#s0080}
----------------------------------------------------------------------------

Due to the incomplete loss of endocrine hormones in *isl1* mutant fish as compared to the complete loss of these hormones in early *Isl1* mouse mutants, we reasoned that other factors might compensate for the loss of *isl1* in fish. Promising candidates are Isl2 proteins and in particular Isl2a which was shown earlier to be able to compensate for Isl1 function during motoneuron differentiation in zebrafish ([@bib20]). To gain insight into possible interactions between *isl* factors in endocrine differentiation, we analyzed pancreatic expression of *isl2a* and *isl2b* mRNA and protein and we performed functional studies using antisense morpholinos. We found that both *isl2* genes are expressed in the pancreatic region between 24 and 72 hpf. Double stains for *islet* mRNAs and for endocrine-specific GFP in neuroD:GFP transgenics revealed that only *isl1* is expressed in endocrine cells while all three *isl-*genes are expressed in overlapping, but slightly different patterns in the pancreatic mesenchyme ([Fig. 3](#f0015){ref-type="fig"}). To further confirm this regulation, we performed immunostainings with a pan-Isl antibody along with an anti-Ins antibody to mark β-cells. Control embryos showed robust anti-Isl signal in the pancreatic islet and a slightly weaker signal in the pancreatic mesenchyme. Consistent with an Isl1 independent regulation of *isl2* genes only in pancreatic mesenchyme, loss of *isl1* in the mutants was sufficient to abolish the endocrine anti-islet antibody signal but not the signal in pancreatic mesenchyme ([Fig. 4](#f0020){ref-type="fig"}B). The lack of islet antibody staining in Ins^+^ cells of *isl1* mutants argues against a cell autonomous role of Isl2 proteins in early endocrine cell differentiation. To exclude that low levels of Isl2 might have a compensatory function in endocrine cell formation, we analyzed *ins* expression in *isl1* mutant embryos injected with *isl2a* translation-blocking MO. Interestingly, immunostainings showed that injection of *isl2a*-MO was sufficient to entirely eliminate pancreatic anti-islet signals in *isl1* mutants. While this suggests efficient knockdown of all remaining Islet proteins by the *isl2a* morpholino injection, it could also indicate that the levels of Isl2b expression in these embryos is below the detection limit or that Isl2b proteins are not recognized by the antibody ([Fig. 4](#f0020){ref-type="fig"}C). In the case of redundant activities, we expected to see a further reduction or even complete loss of endocrine cells in *isl1* mutants/*isl2a* morphants. In contrast, no differences in the number of *ins* expressing cells at 30 hpf and 72 hpf ([Fig. 4](#f0020){ref-type="fig"}D--H and [Table. S3](#s0115){ref-type="fn"}) could be detected between uninjected *isl1* mutants and *isl2a* MO injected mutants ([Fig. 4](#f0020){ref-type="fig"}D). In conclusion, this suggests that among the three *isl*-genes in zebrafish only *isl1* has activity in endocrine cells, while all three genes are expressed in the pancreatic mesenchyme.

Interaction of *isl1* and *isl2* genes during exocrine pancreas development {#s0085}
---------------------------------------------------------------------------

A previous study in zebrafish reported that injection of an *isl1* translation-blocking morpholino caused a concentration dependent reduction of the exocrine pancreas ([@bib49]). As we have shown that there is overlapping expression of three *isl-*genes in pancreatic mesenchyme, we hypothesized that *isl1 and isl2* genes could have overlapping functions in ventral pancreatic bud formation. To test this, we analyzed pancreas formation in *isl1* mutant embryos that were further injected with *isl2a/isl2b*-MO to generate *isl1/2a/2b* triple negative embryos. Analysis of early ventral bud markers at 48 hpf revealed a similar expression pattern for *ptf1/p48* in control and *isl1/2* depleted embryos and a reduced *mnr2a* expression domain in the *isl1/2* depleted embryos. The data suggest that Isl proteins are dispensable for initiation ventral bud formation ([Fig. 5](#f0025){ref-type="fig"}A and B), but might be involved in ventral bud expansion ([Fig. 5](#f0025){ref-type="fig"}C and D). Analyses of *isl1/2* depleted embryos at 76--80 hpf revealed normal formation of the *pdx1*^+^ extra-pancreatic duct ([Fig. 5](#f0025){ref-type="fig"}E and F), but a strong reduction of the exocrine cell marker *trypsin* ([Fig. 5](#f0025){ref-type="fig"}G and H, [Fig. S4](#s0115){ref-type="fn"}).

To address the question of whether *isl-*genes interact during exocrine tissue formation, *trypsin* expression was also further analyzed in embryos lacking individual *isl*-genes or a combination of two *isl*-genes ([Fig. S4](#s0115){ref-type="fn"}). The stainings displayed a variable reduction of *trypsin* expression, very similar to the phenotypes described after injection of *isl1* translation blocking MO ([@bib49]). For quantification, we measured the maximum distance from head to the tail of the *trypsin* expression domain ([Fig. S4](#s0115){ref-type="fn"}, [Table. S4](#s0115){ref-type="fn"}). We found that loss of either *isl1* or *isl2a* alone results in a significant shortening of the *trypsin* expression domains by about 30% and that the shortening is further enhanced to 47% in *isl1*/*2a* double-deficient embryos ([Fig. S4](#s0115){ref-type="fn"}A--F and I). *Isl2b* appears to have only minor functions, as the knockdown did not significantly reduce the *trypsin* domain in control or *isl2a* morphants ([Fig. S4](#s0115){ref-type="fn"}C, D and I). However, *isl2b* morpholino injection did cause a significantly shorter *trypsin* expression when combined with the loss of *isl1* or *isl1/2a* function ([Fig. S4](#s0115){ref-type="fn"}G, H and I).

For further analysis, expression of *trypsin* and *ela3l*, a second exocrine marker with a slightly later onset of expression ([@bib49]), were analyzed by qPCR in 96 hpf embryos. The data confirmed the strong reduction of *trypsin* in *isl1* mutants and revealed a loss of *ela3l* expression in these mutants ([Fig. 5](#f0025){ref-type="fig"}J). While whole mount analyses of 96 hpf embryos confirmed the reduction of *trypsin* expression seen also in 76 hpf embryos ([Fig. S5](#s0115){ref-type="fn"}), the qPCR analyses show that knockdown of *isl2*-genes had only mild and not statistically significant effects on the expression levels of *trypsin* and *ela3l* ([Fig. 5](#f0025){ref-type="fig"}J). In summary the data reveal interactions between mesenchymal *isl1* and *isl2a/b* in non-cell autonomous regulation of exocrine pancreas growth and morphogenesis. The strong reduction of *trypsin* and loss of *ela3l* in *isl1* mutants but not in *isl2* morphants indicates a potential *isl1*-specific function in exocrine tissue specification or maturation.

*Isl1* mutant mice lack two tissues with important non-cell autonomous function during pancreas formation, the dorsal aorta endothelium and the pancreatic mesenchyme ([@bib1; @bib30]). While the dorsal aorta has been shown to form normally in the *isl1* mutant zebrafish ([@bib52]), it is still possible that defects in pancreatic mesenchyme formation may account for the defects in exocrine tissue extension. Notably, the mesenchymal expression of *isl1* mRNA itself is unchanged in the *isl1* embryos ([Fig. 2](#f0010){ref-type="fig"}C and D), indicating that pancreatic mesenchyme is established in the mutants. Analyses of the pancreatic mesenchyme markers *meis3*, *fgf10* and *fgf24* ([@bib36]) also revealed a similar expression in control embryos and in embryos in which the activity of individual or combinations of two or three islet genes has been disrupted ([Figs. 6](#f0030){ref-type="fig"} and [S6](#s0115){ref-type="fn"}). Finally we investigated the contribution of the dorsal aortic endothelium to establishing pancreatic mesenchyme. Analyses of *cloche* mutant embryos (*clo*^*−/−*^), which lack endothelial cells ([@bib45]), revealed normal patterns of *meis3*, *fgf10* and *fgf24* ([Fig. 6](#f0030){ref-type="fig"} D, H and L). Thus, neither *isl-*genes nor the aortic endothelium appear to be required for the formation of pancreatic mesenchyme or for the transcriptional regulation of the identified mediators of exocrine expansion, *fgf10* and *fgf24* within this tissue ([@bib36]). This suggests that the requirement for Isl proteins in pancreatic mesenchyme formation differs between mouse and zebrafish, even though the non-cell autonomous function of *isl*-genes in exocrine pancreas extension appears to be conserved between these organisms.

Distinct function of *isl1* in first and second wave endocrine cells {#s0090}
--------------------------------------------------------------------

In normal pancreas development, the endocrine cell mass increases after 36 hpf as the result of differentiation and proliferation of late forming ventral bud derived endocrine cells ([@bib10; @bib18; @bib39]). Consistent with published data, we find that the control embryos showed increasing numbers of hormone expressing cells types between 24--96 hpf ([Figs. 1](#f0005){ref-type="fig"}, [S2](#s0115){ref-type="fn"} and [Table S1](#s0115){ref-type="fn"}). In *isl1* mutants, we find that the number of Sst expressing cells remains unaltered, while Ins and Gcg expressing cells show an increase in numbers similar to that of the control embryos ([Fig. 1](#f0005){ref-type="fig"}M). In order to determine possible contribution of *isl1* to cell death or proliferation, mutants were analyzed for the presence of apoptotic cell nuclei by TUNEL stains and for mitosis by DNA-incorporation assays using the thymidine analog EdU. TUNEL stains of *hb9:GFP* transgenic embryos at 30 hpf and 48 hpf revealed similar results for control and *isl1* mutant embryos, with some rare TUNEL signals in the environment of the GFP labeled islets but no signals within the islets ([Fig.7](#f0035){ref-type="fig"}A--D). For the EdU incorporation assays, control animals and *isl1* mutants were injected with EdU at 48 hpf and analyzed at 96 hpf. In agreement with previous reports ([@bib18; @bib27; @bib39]), embryos showed EdU incorporation into most of the exocrine cells but in only very few endocrine cells. While *isl1* mutants have less Ins^+^/EdU^+^ cells than control embryos ([Fig. 7](#f0035){ref-type="fig"}G), the proportion of Ins^+^/EdU^+^ cells is similar for both genotypes ([Fig. 7](#f0035){ref-type="fig"}H). This suggests that loss of *isl1* has no major effect on endocrine cell proliferation or survival.

The age-dependent increase of α- and β-cell number in mutants could result from a delayed differentiation of early forming α- and β-cells, or alternatively from the normal onset of hormone expression in late forming second wave cells. In order to distinguish between these options, we used a recently described cell tracking approach that allows differential labeling of early born first- and later born second-wave cells ([@bib6; @bib18]). In these experiments, embryos are injected with mRNA encoding the long-living fluorescent histone variant *H2B-mRFP1*. As the H2B-mRFP1 protein is equally distributed to daughter cells during mitosis, fluorescent intensities per nucleus exponentially decrease with every cell division. DBCs leave the cell-cycle early in development and therefore remain high levels of H2B-mRFP1, even later in development. The VBCs undergo more rounds of cell division and remain proliferative even after onset of hormone expression, which leads to the dilution of RFP label below level of detection ([@bib18]). In the case of normal forming second-wave α- and β-cells, we expected to find RFP^+^ as well as RFP^−^ α- and β-cells. As the early forming Gcg-cells are virtually absent in *isl1* mutants, most 'second wave-derived' Gcg-expressing cells at later stages should be RFP^−^. By contrast, as the number of Sst-expressing cells remains constant between 28--76 hpf we expect most of the Sst-expressing cells to be RFP^+^ in older embryos. To address this question, we injected *H2B-mRFP1* mRNA into one-cell stage eggs and analyzed RFP expression in endocrine cells at 96 hpf. As expected, Ins^+^/RFP^+^ and Ins^+^/RFP^−^ cells were found in mutant fish, while most Sst expressing cells were RFP^+^. In contrast to our expectations, we also found a few Gcg^+^/RFP^+^ cells, possibly indicating a delayed onset of Gcg expression in *isl1* mutant first wave α-cells ([Fig. 8](#f0040){ref-type="fig"} and [Table S6](#s0115){ref-type="fn"}). To determine if hormone^+^ second wave cells are formed in normal numbers, we counted hormone^+^/RFP^−^ endocrine cells in control and *isl1* mutant embryos. While the total number of hormone^+^/RFP^−^ second wave cells is reduced from 32 RFP^−^ cells in control down to 18 RFP^−^ cells in *isl1* mutants, these embryos show no significant difference in the amount of ventral bud derived Ins^+^/RFP^−^ and Gcg^+^/RFP^−^ cells. This suggests that differentiation of Ins- and Gcg-expressing cells from the later-arising VBCs is not affected by the loss of *isl1.* However, there is a reduction of late forming Sst-expressing cells. These data show a different requirement for *isl1* in early versus late forming endocrine cells.

Discussion {#s0095}
==========

Here, we present a genetic analysis of pancreatic *isl-*gene function in zebrafish. We show that *isl1* is co-expressed with *isl2a* and *isl2b* in pancreatic mesenchyme, and that all three *isl*-genes have additive functions in exocrine pancreas expansion. Further, we show that *isl1* alone is active in endocrine cells, we reveal cell type specific requirements for *isl1* in endocrine cell maturation and we show that these requirements are different in first and second wave endocrine cells.

Interactions of *isl1* and *isl2* genes in exocrine pancreas formation {#s0100}
----------------------------------------------------------------------

Various studies in mouse and chicken have demonstrated that signal exchange between pancreatic mesenchyme and pre-pancreatic endoderm is a major regulator of early pancreas morphogenesis and exocrine tissue induction ([@bib13]). While the molecular nature of the involved signals is still not completely understood, explant studies performed as part of the *Isl1* mouse knock out analyses placed *Isl1* upstream of a mesenchymal signal that regulates exocrine pancreas formation ([@bib1]). Similarly, the strong reduction of *trypsin* in *isl*-depleted zebrafish embryos argues for a role for zebrafish *isl*-genes in regulating an exocrine pancreas inducing or expanding factor. Interestingly, in mouse, loss of *Isl1* alone is sufficient to prevent activation of exocrine markers in dorsal pancreatic bud derived tissues. By contrast, we find that in zebrafish pancreatic mesenchyme, three *isl*-genes contribute in an additive manner to exocrine expansion. One possibility is that Isl proteins have redundant activities, which is also supported by the observation that *isl2a* can functionally compensate for loss of *isl1* in motoneuron specification ([@bib20]). While pancreatic *isl2* functions have not been addressed in mammals, it is interesting to note that *isl2* expression has been reported for the human pancreas ([@bib33]).

In this work, we show that in Isl protein*-*depleted embryos, mRNA expression of *meis3*, *fgf10 and fgf24* is not significantly reduced in the pancreatic mesenchyme. This suggests that *isl*-genes in fish are not required for the formation of pancreatic mesoderm, as is the case in mouse. Notably, in the *Isl1* mutant mouse, the loss of dorsal pancreatic mesenchyme is associated with a loss of the dorsal aorta by apoptosis ([@bib1]). The dorsal aorta in mouse has direct contact with the pancreatic mesenchyme and the lack of endothelial cells prevents the formation of the pancreatic mesenchyme ([@bib21]). While the presence of the dorsal aorta in *isl1* mutant zebrafish ([@bib52]) might explain the weaker phenotype in the fish, we also show that a loss of dorsal aorta in *cloche* mutants has no effect on the expression of pancreatic mesenchyme markers. In agreement with a previous report showing normal expression of trypsin in *cloche* mutants ([@bib10]), our results suggest that tissues other than the dorsal aorta regulate pancreatic mesenchyme induction in fish. Consistent with this notion, it was shown that between 26 and 29 hpf, *fgf10* and *fgf24* expressed in the endoderm induce pancreatic mesenchyme identity within the lateral plate mesoderm and controls *isl1* and *meis3* expression in this mesenchyme ([@bib36]). After 29 hpf, Fgfs expressed in the pancreatic mesenchyme are required for exocrine tissue expansion and correct specification of the hepatopancreatic duct system ([@bib7; @bib36]). The normal presence of *fgf10* and *fgf24* mRNA in the mesenchyme of *isl-*depleted embryos in combination with the reduced size of the exocrine pancreas in the *isl1* mutants suggests that Isl proteins must regulate other paracrine factors and that Isl proteins either alone or in parallel to Fgf10/24 promote exocrine tissue expansion.

*Isl* functions in endocrine cell differentiation {#s0105}
-------------------------------------------------

In amniotes, first wave endocrine cells can be distinguished from second wave cells by several features including a reduced spectrum of cell types and a lack of cell renewal in first wave cells. Studies in zebrafish only recently showed that production of first and second wave cells, and the lack of self-renewal capacity, is evolutionary conserved between mammals and fish ([@bib18]). In zebrafish, the first wave cells display the same spectrum of hormone expressing cell types as are found in second wave cells. The role of first wave cells and the reason why zebrafish embryos establish the different types of first wave cells is currently not known. One possible explanation is a requirement for a mother-independent glucose regulation that is happening already in the fish embryo ([@bib9; @bib22]). Such a function implies a similar physiological role of first and second wave cells and possibly a similar molecular regulation of differentiation. However, we find that loss of *isl1* has different effects on first and second wave cell maturation. This underscores the dissimilarity between first and second wave cells, and suggests that studies on first wave cells may provide only limited information relevant to the behavior of the cells of the mature organ, namely the second wave cells.

Most surprisingly, we found that loss of *isl1* had no statistically significant effect on the number of Ins- and Gcg-expressing second wave cells. As these hormones are strongly reduced in the pancreas-specific *Isl1* mouse knock-out ([@bib8]), this could indicate that *isl1* functions are not only different in first and second wave zebrafish cells, but also with respect to their function in second wave cell maturation, proliferation and survival in fish versus mouse. Mutant zebrafish start to develop obvious defects after 4 dpf, e.g. in blood circulation, that affect the general fitness of the embryo. Therefore our studies were restricted to the first 4--5 days of development, during which time only few second wave cells in the vicinity of the primary islet are established. Additional experiments that overcome late embryonic lethality of *isl1* fish mutants will be required to address possible later functions. Our studies revealed no obvious differences in embryonic β-cell survival and proliferation between control and *isl1* mutants. However, only second wave cells are supposed to be proliferatively active ([@bib18]). As our data suggest normal formation of second wave α- and β-cells, the reduced number of Ins^+^/EdU^+^ cells in *isl1* mutants could indicate reduced β-cell proliferation. Furthermore, expression of endocrine hormones is initiated early during endocrine cell maturation and the observed presence of hormones does not exclude defects during later steps of maturation. Molecular markers that are used to distinguish later maturation stages in mammalian β-cells are currently not established in fish. To further dissect the role of *isl1*, it will be important to learn more about the targets of Isl proteins.

Results from transcriptome analyses of purified neuronal cells, and tissues isolated from control and *Isl1* mutant animals, provided hints for potential Isl1 targets in sensory cells ([@bib46]). Similar to the expression in endocrine cells, Isl1 is also active in differentiating and mature neuronal cells. It is therefore interesting to note that the transcriptome comparison links Isl1 function to the molecular machineries driving cell differentiation as well as to mature cell function. More recently, major progress has also been made in identifying additional pancreatic Isl1 targets, including transcription factors such as *MafA* and *arx* ([@bib8; @bib34]) as well as known cell-cycle regulators such as *Cyclin D1* or *c-Myc* ([@bib15]). The loss of pancreas specific *arx* expression not only in mouse but also in zebrafish *isl1* mutants provides promising evidence for a conserved molecular function for *isl1* in endocrine cell maturation.

Conclusion {#s0110}
==========

Pancreatic expression of vertebrate *Isl1* genes is highly conserved in pancreatic mesenchyme and in post-mitotic endocrine cells. Our genetic analysis in zebrafish is the first that addresses pancreatic *isl1* functions outside the mouse. Our analyses reveal a novel interaction between *isl1* and *isl2* genes in exocrine pancreas expansion and they implicate cell type specific requirements for *isl1* in endocrine cell maturation. While our data suggest that the conserved expression correlates with conserved requirements for *islet* genes in non-cell autonomous exocrine pancreas expansion and cell-autonomous endocrine cell maturation, they also highlight species-specific differences in pancreatic *isl1* functions. In particular we find differences with respect to the requirement for *isl*-genes in pancreatic mesenchyme formation, the induction of hormone expression in first wave cells, and the cell type specific requirements in endocrine cells.

Appendix A. Supplementary materials {#s0120}
===================================

Fig. S1Phenotype of *isl1* mutant zebrafish compared to wildtype. Images of live control embryos (A--E) and *isl1* mutant embryos (F--J) taken between 24--120 hpf. (F--J) Mutant embryos appear normal during the first two days after fertilization but show heart edema at 72 hpf (black arrow head in H, I and J). At later stages, the *isl1* mutant fish show various defects including smaller eyes, malformed somites and a non-inflated swim bladder (sb).

Fig. S2Expression of *ins*, *sst* and *gcg* mRNA in control and *isl1 mutants* mRNA expression of *ins* (A--F), *sst* (G--L) and *gcg* (M--R) in the pancreatic islets of control embryos and *isl1* mutants at the indicated stages. Note that in mutants the expression of *ins* and *sst* is strongly reduced at all stages analyzed, while *glu* is virtually absent at 52 hpf and strongly reduced at older stages. Images show a dorsal view with anterior to the left.

Fig. S3Control and *isl1* mutants show similar numbers of *isl1* and *pax6b* mRNA expressing cell in the pancreatic islets.

Fig. S4Dosedependent reduction of *trypsin* expression following genetic and morpholino-based loss of *isl* gene function at 76 hpf. Examples of *trypsin* mRNA stainings that were summarized in Fig. 5C. Shown are control (A--D) and *isl1* mutant embryos (E--H) that were injected with indicated combinations of *isl2a* and *isl2b* morpholinos. Images show a dorsal view with anterior to the left. (I) Quantification of the length of *trypsin* mRNA expression in control and *isl1* mutant embryos injected with the indicated morpholinos. Bars show mean+SEM.

Fig. S5*Trypsin* mRNA expression following genetic and morpholino-based loss of *isl* gene function at 96 hpf. Note that *isl1* mutants and *isl2a/2b* double morphants display similar *trypsin* pattern.

Fig. S6Pancreatic mesenchyme in control and *isl1* mutant/ *isl2a* & *isl2b* morphant embryos (48 hpf). Expression pattern of mesenchymal *fgf24* (A--H) and *meis3* (I--P). Single or multiple loss of *isl* genes has no impact on the mRNA expression pattern. Images show a ventral view with anterior to the left.
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![Reduced expression of endocrine hormones in *isl1* mutants. (A--F) Confocal image projections of the pancreatic islet in control (A--C) and *isl1*^*−/−*^ embryos (D--F) that were co-immunostained for Ins (green) and Sst (red) at 28 hpf (A, D), 48 hpf (B, E) and 76 hpf (C, F). (G--L) Immunostainings for Gcg (purple) in control (G--I) and in *isl1*^*−/−*^ embryos (J--L) at 48 hpf (G, J), 76 hpf (H, K) and 96 hpf (I, L). All embryos are shown from ventral with the anterior to the left. (M) Quantitative analysis of hormone expressing cells in control and *isl1*^−/−^ embryos. Bars show mean+SEM. (N) Relative expression levels of *ins*, *gcga* and *sst2* mRNA in *isl1*^−/−^ mutant fish in relation to control littermates as revealed by qPCR analyses of whole embryo RNA preparations, normalized to *EF1α*.](gr1){#f0005}

![Unchanged expression of early endocrine markers in *isl1* mutants. Whole mount in situ hybridizations for *isl1* (A--F) and *pax6b* (G--J) mRNA in control (A, C, E, G, I) and in *isl1*^*−/−*^ embryos (B, D, F, H, J) at 24 hpf (A, B, G, H), 48 hpf (C, D) and 76 hpf (E, F, I, J). Note that the pattern and intensity of *isl1* signals in the pancreatic mesenchyme (black arrow head) and in the endocrine islet (white arrow head) is indistinguishable in control and mutant embryos. Embryos are shown from ventral with anterior to the left. (K--P) Whole mount in situ hybridizations for *arx*. (K, N) Dorsal view of control embryos at 24 hpf (K) and 48 hpf (N). Insets mark the position of the pancreatic area shown in higher magnification panels (L M, O, P). Images show a ventral view of control (L, O) and *isl1*^*−/−*^ mutant (M, P) embryos. (Q) qPCR analysis for hormone and transcription factor encoding mRNA of isolated pancreata from 96 hpf old embryos. Shown are relative expression levels in pancreata of mutant as compared to control embryos, normalized to the relative expression levels of *ins* obtained for 96 hpf whole embryonic mRNA.](gr2){#f0010}

![\\Pancreatic expression of *isl1*, *isl2a* and *isl2b.* Comparison of *isl1* (A--E), *isl2a* (F--J) and *isl2b* mRNA (K--O) expression at 24 hpf (B, C, G, H, L, M) and 48 hpf (A, D--F, I--K, N, O). Embryos are shown from the dorsal (A, F, K) or ventral view (rest). Insets shown in the overview images (A, F, K) indicate the relative position of the higher resolution images shown on the right side. The mRNA stains were performed in *tg\[neuroD:GFP\]* embryos in which immunofluorescence detection of GFP (green signals in C, E, H, J, M, O) was used to highlight endocrine cells (arrows mark the position of the pancreatic islet). Note that only *isl1* signals overlap with GFP. Expression of *isl2a* is found in the mesenchyme anterior the endocrine cells at 24 hpf and left of the GFP labeled endocrine cells at 48 hpf in a pattern overlapping with that of the mesenchymal *isl1* expression (arrowheads mark similar position in all embryos). Signals for *isl2b* are also found anterior to the endocrine cells at 24 hpf (arrowhead) and in a broader mesenchymal domain directly adjacent to the GFP signals at 48 hpf.](gr3){#f0015}

![*isl2a* does not contribute to endocrine cell formation. (A--C) Immunostainings for Ins (green) and Isl-proteins (red) in the pancreatic region of control (A), *isl1* mutant (B), and *isl1* mutant/MO^*isl2a*^ injected embryos (C) at 48 hpf. (D) Quantification of *ins* mRNA positive cells and examples of corresponding in situ stains for *ins* mRNA in *isl1* mutants (E, G), and in *isl1* mutant, MO^*isl2a*^ injected embryos (F, H) at 30 hpf (E, F) and 72 hpf (G, H). Bars show mean+SEM.](gr4){#f0020}

![Overlapping activities of three *isl*-genes in exocrine tissue formation. (A, B) Pancreatic *ptf1*/*p48* mRNA expression is similar in control (A) and *isl1*^*−/−*^+MO^*isl2a/2b*^ embryos (B) at 48 hpf. (C, D) Differently, pancreatic *mnr2a* mRNA expression is reduced in *isl1*^*−/−*^+MO^*isl2a/2b*^ embryos as compared to control embryos. (E, G) *pdx1* mRNA expression at 80 hpf reveals a similar morphology of the extrapancreatic duct (arrow) in control and *isl1*^*−/−*^+MO^*isl2a/2b*^ embryos. Note the reduced gut specific *pdx1* signals (asterisk) in the *isl*-depleted embryos. (G, H) *trypsin* mRNA expressing in exocrine tissue of a control embryo (G) and in an *isl1*^*−/−*^+MO^*isl2a/2b*^ embryos (G) at 76 hpf. (I) Quantitative analyses on the length of *trypsin* mRNA expression domain in control and triple *isl* gene deficient embryos at 76 hpf. Embryos are shown from ventral with anterior to the left (A--F) or dorsal with anterior to the left (G, H). *P*-values for significant changes are indicated. (J) qPCR analysis for mRNA expression levels of *trypsin* and *ela3l* in 96 hpf old whole embryos, normalized to *EF1α*. Coloring of the bars corresponds to the same genotypes presented in (I). Bars show mean+SEM.](gr5){#f0025}

![Formation of pancreatic mesenchyme is independent of *isl* gene function. Neither the loss of all three *isl*-genes nor absence of vascularization in *cloche* mutants results in a loss of *fgf10*, *fgf24* or *meis3*. Expression patterns of *meis3* (A--D), *fgf10* (E--H) and *fgf24* (I--L) in pancreatic mesenchyme of control embryos (B, F, J), *isl1*/*2a*/*2b* depleted embryos (C, G, K) and *cloche* mutants (D, H, L). All images are ventral with the exception of A, E, I which are dorsal views. Anterior is to the left. Insets in A, E, I mark the position of the higher resolution images shown on the right side.](gr6){#f0030}

![TUNEL and EdU assays on control and mutant embryos. (A--D) Confocal image projections of 30 hpf (A+B) and 48 hpf (C+D) old control and *isl1* mutant embryos in the *tg\[hb9:GFP*\] background after TUNEL labeling for apoptotic cells. The arrow highlights individual TUNEL^+^ cells in the vicinity of the GFP labeled islet. No TUNEL^+^ cells were found within the pancreatic islet of control or mutant fish at all analyzed stages. (E+F) Confocal sections of 96 hpf embryos labeled for Ins (in red) and EdU (in blue). Embryos were treated with EdU from 48 hpf to 96 hpf. Note that very few EdU^+^ cell are present within the islet (highlighted by yellow circle), while most of the nuclei in the surrounding exocrine tissue are EdU-positive. All images show ventral view, anterior to the left. (G) Numbers of Ins^+^ and Ins^+^/EdU^+^ cells in control and *isl1* mutants. (H) Percentage of EdU^+^/Ins^+^ cells in relation to the number of Ins^+^ cells. Bars show mean+SEM.](gr7){#f0035}

![Endocrine hormone expression in first and second wave endocrine cells in control and *isl1* mutant embryos. Single plane views from confocal images of the primary islets from control (A--C) and *isl1* mutants (D--E). Embyros were injected with H2B-RFP (in red) encoding mRNA at the one cell stage and were immunostained (in green) for Ins (A, D), Sst (B, E) and Gcg (C, F) at 96 hpf. Cells that left cell-cycle early in development show a red nuclear label due to the injecetion of *H2B-RFP* encoding mRNA at the one cell stage. Arrowheads indicate examples of hormone^+^/RFP^+^ cells (refered to as DBCs), while arrows indicates examples of hormone^+^/RFP^−^ cells (referred to as VBCs). (G, H) Quantification of hormone^+^ DBCs (G) and VBCs (H) in control (black bars) and *isl1* mutant embryos (white bars). Note that *isl1* mutants show significantly reduced numbers for all DBCs, while only the number of Sst expressing VBCs cells is significantly reduced. Bars show mean+SEM.](gr8){#f0040}
